Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Jul 6, 2018
    More than Half of Industry Payments Reported to CMS in 2017 Were for Research
  • Jul 3, 2018
    Minnesota Sues Purdue Over Opioid Marketing
  • Jul 3, 2018
    CVM Sends Ad Warning Letter Over Lack of Risk Info
  • Jul 2, 2018
    NAD Recommends Company Discontinue Probiotic Product Claims
  • Jul 2, 2018
    NAD Recommends Two Dietary Supplement Companies Discontinue Claims for Hearing and Triathlete Products
  • Jul 2, 2018
    Australia Launches Website to Explain Revised Ad Code
  • Jun 29, 2018
    OPDP Issues Untitled Letters to Pfizer and Arog Pharmaceuticals
  • Jun 29, 2018
    Poll Finds Public Support for Prices in Drug Ads
  • Jun 28, 2018
    Virginia Sues Purdue Pharma Over Opioid Marketing
  • Jun 28, 2018
    Nevada Issues First Sales Rep Report
  • More

Good Clinical Practice

  • Oct 16, 2018
    FDA Issues Guidances To Aid Innovative Clinical Trials
  • Oct 15, 2018
    FDA Clarifies Obligations To Comply with Current Regulations, Revised Common Rule
  • Oct 9, 2018
    NIH Panel Calls for ‘Cultural Shift’ in Research Involving Pregnant and Lactating Women
  • Oct 9, 2018
    CTTI Issues Decentralized Trial Recommendations
  • Oct 5, 2018
    CDRH Plans To Issue Final HDE Guidance This Fiscal Year
  • Oct 3, 2018
    FDA Final Guidance Details Timing of Atopic Dermatitis Pediatric Studies
  • Oct 1, 2018
    Trial Sites Look for Communication, Protocol Design and Partnership
  • Oct 1, 2018
    Lupus Group Presents Consensus Proposals To FDA for Advancing Clinical Trials
  • Oct 1, 2018
    FDA Debars Investigator for Fabricated Data
  • Oct 1, 2018
    FDA Issues Draft Guidance on Adaptive Trial Designs
  • More

U.S. Food Labeling

  • Jul 10,2014
    USDA Looks to Extend BioPreferred Labeling Program to Older Products Considered ‘Innovative’
  • Jun 27,2014
    Explanatory Guidance Outlines Requirements for ‘Gluten-Free’ Labeling in Plain English
  • Jun 25,2014
    FDA OKs Tuna Labels Without “Below Standard in Fill” Disclosure
  • Jun 24,2014
    Warning Labels for Sugary Drinks in Calif. Killed Off in Committee
  • Jun 16,2014
    California Assembly Takes Up Sugary Drink Labeling Bill
  • Jun 16,2014
    High Court: Companies Can Sue Over FDA-approved Advertising
  • Jun 13,2014
    Food Trade Groups Sue Vermont To Overturn GMO Labeling Law
  • Jun 12,2014
    Supreme Court: Companies Can Sue Over FDA-approved Labeling Claims
  • Jun 5,2014
    Calif. GMO Labeling Measure Falls in Two Votes
  • May 29,2014
    FDA Sets Public Meeting To Get Public Input on Proposed Changes to Nutrition Facts Panel
  • More

FDA Regulation & Enforcement

  • Oct 14, 2021
    FDA Publishes Guidance Setting Voluntary Sodium Reduction Targets for Food
  • Oct 7, 2021
    Three Advertising and Communication Guidances Gain OMB Information Collection Approval
  • Oct 7, 2021
    Court Refuses To Reject HHS OIG Advisory Opinion on Kickback Implications of Drug Co-Pay Program
  • Sep 30, 2021
    Former Insys Sales Rep Pleads Guilty to Fraud Conspiracy Charge Arising From Sham Speaker Program
  • Sep 30, 2021
    Teva Settles Opioid Claims with Louisiana
  • Sep 30, 2021
    FSIS Revises Guideline on Food Products Packaged as Kits
  • Sep 22, 2021
    Consent Decree Bars Outsourcing Facility From Producing Drugs Until It Complies with FDA Mandates
  • Sep 17, 2021
    Endo Settles New York Cases Involving Opioid Marketing
  • Sep 16, 2021
    DOJ Urges Full D.C. Circuit Review of Decision Barring FDA from Banning Particular Uses of Devices
  • Sep 15, 2021
    FSIS Asks for Comments on Cell Cultured Meat, Poultry Labeling
  • More

Medical Devices

  • Feb 1, 2017
    FDA Finalizes Guidance for Complying with Combination Product cGMP Requirements
  • Jan 31, 2017
    AdvaMed Wants No Final Rule Requiring Submission of Home-Use Device Labeling, Package Inserts to FDA
  • Jan 26, 2017
    FDA Warns of Cybersecurity Vulnerabilities in Data Transmitter Used with Implantable Devices
  • Jan 24, 2017
    Importer of Counterfeit and Misbranded Contact Lenses from Asia Sentenced to 46 Months in Prison
  • Jan 19, 2017
    FDA Discussion Paper Presents ‘Possible Approach’ to Agency Oversight of Laboratory-Developed Tests
  • Jan 12, 2017
    Shire Pharmaceuticals Reaches $350 Million Resolution of Dermagraft Kickback Allegations
  • Jan 9, 2017
    Substantial Equivalence, Next Generation Sequencing Guidance on CDRH’s Priority List for FY 2017
  • Jan 9, 2017
    Final Guidance Issued on Benefit, Risk Factors That FDA Considers When Dealing with Marketed Devices
  • Jan 4, 2017
    Final FDA Guidance on Device Accessory Classification Stresses Use of De Novo Procedure
  • Dec 28, 2016
    Agency Finalizes Guidance for Device Manufacturers on Managing Postmarket Cybersecurity Risks
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.